Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity

Journal of Lipid Research

Volumn 53, Issue 11, 2012, Pages 2318-2330

  Shi, Xiaolei ^a   Yao, Dan ^a   Gosnell, Blake A ^a   Chen, Chi ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINOTRANSFERASE; COCAINE; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; IN VITRO STUDY; IN VIVO STUDY; LIPID METABOLISM; LIPIDOMICS; LIVER PROTECTION; LIVER TOXICITY; MALE; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CHROMATOGRAPHY, LIQUID; COCAINE; DRUG-INDUCED LIVER INJURY; FATTY ACIDS; LIPID METABOLISM; LIVER; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; PALMITOYLCARNITINE; PPAR ALPHA;

EID: 84867356237     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M027656     Document Type: Article

References (63)

1. Nutt, D., L. A. King, W. Saulsbury, and C. Blakemore. 2007. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 369: 1047-1053. (Pubitemid 46436128)
2. Laso, W. 2001. Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol. J. Pharmacol. 53: 57-60.
3. Knuepfer, M. M. 2003. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol. Ther. 97: 181-222. (Pubitemid 36165169)
4. Cascales, M., A. Alvarez, P. Gasco, L. Fernandez-Simon, N. Sanz, and L. Bosca. 1994. Cocaine-induced liver injury in mice elicits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology. 20: 992-1001. (Pubitemid 24296509)
5. Shuster, L., F. Quimby, A. Bates, and M. L. Thompson. 1977. Liver damage from cocaine in mice. Life Sci. 20: 1035-1041.
6. Jover, R., X. Ponsoda, M. J. Gomez-Lechon, C. Herrero, J. del Pino, and J. V. Castell. 1991. Potentiation of cocaine hepatotoxicity by ethanol in human hepatocytes. Toxicol. Appl. Pharmacol. 107: 526-534.
7. Kothur, R., F. Marsh, and G. Posner. 1991. Liver function tests in nonparenteral cocaine users. Arch. Intern. Med. 151: 1126-1128.
8. Cantilena, L. R., S. A. Cherstniakova, G. Saviolakis, R. Kahn, A. Elkashef, L. Rose, and F. Vocci. 2007. Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during phase 1 clinical trials. Contemp. Clin. Trials. 28: 695-704. (Pubitemid 47499250)
9. Porter, J. M., M. S. Sussman, and G. M. Rosen. 1988. Cocaine-induced hepatotoxicity. Hepatology. 8: 1713.
10. Wanless, I. R., S. Dore, N. Gopinath, J. Tan, R. Cameron, E. J. Heathcote, L. M. Blendis, and G. Levy. 1990. Histopathology of cocaine hepatotoxicity. Report of four patients. Gastroenterology. 98: 497-501. (Pubitemid 20037937)
11. Boelsterli, U. A., and C. Goldlin. 1991. Biomechanisms of cocaine-induced hepatocyte injury mediated by the formation of reactive metabolites. Arch. Toxicol. 65: 351-360.
12. Selim, K., and N. Kaplowitz. 1999. Hepatotoxicity of psychotropic drugs. Hepatology. 29: 1347-1351. (Pubitemid 29211032)
13. Kloss, M. W., G. M. Rosen, and E. J. Rauckman. 1984. Cocaine-mediated hepatotoxicity. A critical review. Biochem. Pharmacol. 33: 169-173. (Pubitemid 14191041)
14. Kovacic, P. 2005. Role of oxidative metabolites of cocaine in toxicity and addiction: oxidative stress and electron transfer. Med. Hypotheses. 64: 350-356. (Pubitemid 40022676)
15. Evans, M. A. 1983. Role of protein binding in cocaine-induced hepatic necrosis. J. Pharmacol. Exp. Ther. 224: 73-79. (Pubitemid 13171033)
16. Masini, A., D. Gallesi, F. Giovannini, T. Trenti, and D. Ceccarelli. 1997. Membrane potential of hepatic mitochondria after acute cocaine administration in rats - the role of mitochondrial reduced glutathione. Hepatology. 25: 385-390. (Pubitemid 27069059)
17. Kloss, M. W., G. M. Rosen, and E. J. Rauckman. 1983. N-demethylation of cocaine to norcocaine. Evidence for participation by cytochrome P-450 and FAD-containing monooxygenase. Mol. Pharmacol. 23: 482-485. (Pubitemid 13116874)
18. Zimmerman, E. F., R. B. Potturi, E. Resnick, and J. E. Fisher. 1994. Role of oxygen free radicals in cocaine-induced vascular disruption in mice. Teratology. 49: 192-201. (Pubitemid 24113772)
19. Vergeade, A., P. Mulder, C. Vendeville-Dehaudt, F. Estour, D. Fortin, R. Ventura-Clapier, C. Thuillez, and C. Monteil. 2010. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ. Free Radic. Biol. Med. 49: 748-756.
20. Dietrich, J. B., A. Mangeol, M. O. Revel, C. Burgun, D. Aunis, and J. Zwiller. 2005. Acute or repeated cocaine administration generates reactive oxygen species and induces antioxidant enzyme activity in dopaminergic rat brain structures. Neuropharmacology. 48: 965-974. (Pubitemid 40602604)
21. Nicholson, J. K., and I. D. Wilson. 2003. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2: 668-676. (Pubitemid 37361770)
22. Chen, C., F. J. Gonzalez, and J. R. Idle. 2007. LC-MS-based metabolomics in drug metabolism. Drug Metab. Rev. 39: 581-597. (Pubitemid 47355739)
23. Johnson, C. H., and F. J. Gonzalez. 2012. Challenges and opportunities of metabolomics. J. Cell Physiol. 227: 2975-2981.
24. Sreekumar, A., L. M. Poisson, T. M. Rajendiran, A. P. Khan, Q. Cao, J. Yu, B. Laxman, R. Mehra, R. J. Lonigro, Y. Li, et al. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 457: 910-914.
25. Chen, C., Y. M. Shah, K. Morimura, K. W. Krausz, M. Miyazaki, T. A. Richardson, E. T. Morgan, J. M. Ntambi, J. R. Idle, and F. J. Gonzalez. 2008. Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis. Cell Metab. 7: 135-147. (Pubitemid 351168558)
26. Shi, X., D. Yao, and C. Chen. 2012. Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J. Biol. Chem. 287: 6336-6349.
27. Patkar, A. A., S. Rozen, P. Mannelli, W. Matson, C. U. Pae, K. R. Krishnan, and R. Kaddurah-Daouk. 2009. Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl.). 206: 479-489.
28. Wiener, H. L., and M. E. Reith. 1990. Differential effects of daily administration of cocaine on hepatic and cerebral glutathione in mice. Biochem. Pharmacol. 40: 1763-1768. (Pubitemid 20337955)
29. Janero, D. R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9: 515-540. (Pubitemid 120036914)
30. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
31. Bylesjö, M., M. Rantalainen, O. Cloarec, J. K. Nicholson, E. Holmes, and J. Trygg. 2006. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemometr. 20: 341-351.
32. Brady, L. J., and C. L. Hoppel. 1983. Effect of diet and starvation on hepatic mitochondrial function in the rat. J. Nutr. 113: 2129-2137. (Pubitemid 14204926)
33. Vatamaniuk, M. Z., O. V. Horyn, O. K. Vatamaniuk, and N. M. Doliba. 2003. Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 72: 1871-1882. (Pubitemid 36174023)
34. Chen, C., X. Ma, M. A. Malfatti, K. W. Krausz, S. Kimura, J. S. Felton, J. R. Idle, and F. J. Gonzalez. 2007. A comprehensive investigation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism in the mouse using a multivariate data analysis approach. Chem. Res. Toxicol. 20: 531-542. (Pubitemid 46548699)
35. Desvergne, B., L. Michalik, and W. Wahli. 2006. Transcriptional regulation of metabolism. Physiol. Rev. 86: 465-514.
36. van Raalte, D. H., M. Li, P. H. Pritchard, and K. M. Wasan. 2004. Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future. Pharm. Res. 21: 1531-1538. (Pubitemid 41184380)
37. Martin, P. G., H. Guillou, F. Lasserre, S. Dejean, A. Lan, J. M. Pascussi, M. Sancristobal, P. Legrand, P. Besse, and T. Pineau. 2007. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology. 45: 767-777. (Pubitemid 46450628)
38. Thompson, M. L., L. Shuster, and K. Shaw. 1979. Cocaine-induced hepatic necrosis in mice - the role of cocaine metabolism. Biochem. Pharmacol. 28: 2389-2395. (Pubitemid 9253330)
39. Ndikum-Moffor, F. M., T. R. Schoeb, and S. M. Roberts. 1998. Liver toxicity from norcocaine nitroxide, an N-oxidative metabolite of cocaine. J. Pharmacol. Exp. Ther. 284: 413-419. (Pubitemid 28109573)
40. Galloway, M. P. 1988. Neurochemical interactions of cocaine with dopaminergic systems. Trends Pharmacol. Sci. 9: 451-454. (Pubitemid 19006220)
41. Young, J. B., and L. Landsberg. 1977. Catecholamines and intermediary metabolism. Clin. Endocrinol. Metab. 6: 599-631. (Pubitemid 8200717)
42. Barth, E., G. Albuszies, K. Baumgart, M. Matejovic, U. Wachter, J. Vogt, P. Radermacher, and E. Calzia. 2007. Glucose metabolism and catecholamines. Crit. Care Med. 35: S508-S518. (Pubitemid 47312187)
43. Vaughan, M. 1966. Second symposium on catecholamines. Lipid metabolism. Introductory remarks. Pharmacol. Rev. 18: 215-216.
44. Wenke, M. 1966. Effects of catecholamines on lipid metabolism. Adv. Lipid Res. 4: 69-105.
45. Lundholm, L., and E. Mohme-Lundholm. 1959. The effect of cocaine and adrenaline on blood lactic acid and oxygen consumption in rabbits. Acta Pharmacol. Toxicol. (Copenh.). 15: 257-264.
46. Ojuka, E. O., J. D. Bell, G. W. Fellingham, and R. K. Conlee. 1996. Cocaine and exercise: alteration in carbohydrate metabolism in adrenodemedullated rats. J. Appl. Physiol. 80: 124-132. (Pubitemid 26034854)
47. Tuncel, M., Z. Wang, D. Arbique, P. J. Fadel, R. G. Victor, and W. Vongpatanasin. 2002. Mechanism of the blood pressure - raising effect of cocaine in humans. Circulation. 105: 1054-1059. (Pubitemid 34212613)
48. MacLachlan, P. L., and H. C. Hodge. 1939. The influence of cocaine feeding on the liver lipids of the white mouse. J. Biol. Chem. 127: 721-726.
49. Odeleye, O. E., M. C. Lopez, B. T. Smith, C. D. Eskelson, and R. R. Watson. 1992. Cocaine hepatotoxicity during protein undernutrition of retrovirally infected mice. Can. J. Physiol. Pharmacol. 70: 338-343.
50. Rajab, R., E. Stearns, and S. Baithun. 2008. Autopsy pathology of cocaine users from the Eastern district of London: a retrospective cohort study. J. Clin. Pathol. 61: 848-850. (Pubitemid 351969731)
51. Gottfried, M. R., M. W. Kloss, D. Graham, E. J. Rauckman, and G. M. Rosen. 1986. Ultrastructure of experimental cocaine hepatotoxicity. Hepatology. 6: 299-304. (Pubitemid 16144883)
52. Weinberg, G. L., R. Ripper, S. Bern, B. Lin, L. Edelman, G. Digregorio, M. Piano, and D. L. Feinstein. 2011. Pioglitazone attenuates acute cocaine toxicity in rat isolated heart: potential protection by metabolic modulation. Anesthesiology. 114: 1389-1395.
53. Chen, C., K. W. Krausz, Y. M. Shah, J. R. Idle, and F. J. Gonzalez. 2009. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem. Res. Toxicol. 22: 699-707.
54. Fromenty, B., and D. Pessayre. 1995. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. 67: 101-154.
55. Devi, B. G., and A. W. Chan. 1996. Cocaine-induced peroxidative stress in rat liver: antioxidant enzymes and mitochondria. J. Pharmacol. Exp. Ther. 279: 359-366. (Pubitemid 27166932)
56. Havel, R. J. 2010. Triglyceride-rich lipoproteins and plasma lipid transport. Arterioscler. Thromb. Vasc. Biol. 30: 9-19.
57. Lettéron, P., A. Sutton, A. Mansouri, B. Fromenty, and D. Pessayre. 2003. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology. 38: 133-140.
58. Boess, F., F. M. Ndikum-Moffor, U. A. Boelsterli, and S. M. Roberts. 2000. Effects of cocaine and its oxidative metabolites on mitochondrial respiration and generation of reactive oxygen species. Biochem. Pharmacol. 60: 615-623. (Pubitemid 30604243)
59. Sáez, C. G., P. Olivares, J. Pallavicini, O. Panes, N. Moreno, T. Massardo, D. Mezzano, and J. Pereira. 2011. Increased number of circulating endothelial cells and plasma markers of endothelial damage in chronic cocaine users. Thromb. Res. 128: e18-e23.
60. Liu, C., A. Redheuil, R. Ouwerkerk, J. Lima, D. Bluemke, and S. Lai. 2010. Cocaine use as an independent predictor of cardiac steatosis: initial experience by 1H spectroscopy. J. Cardiovasc. Magn. Reson. 12(Suppl. 1): O90.
61. Clugston, R. D., H. Jiang, M. X. Lee, R. Piantedosi, J. J. Yuen, R. Ramakrishnan, M. J. Lewis, M. E. Gottesman, L. S. Huang, I. J. Goldberg, et al. 2011. Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study. J. Lipid Res. 52: 2021-2031.
62. Lieber, C. S., S. J. Robins, and M. A. Leo. 1994. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol. Clin. Exp. Res. 18: 592-595. (Pubitemid 24189283)
63. Wang, Y., D. Botolin, J. Xu, B. Christian, E. Mitchell, B. Jayaprakasam, M. G. Nair, J. M. Peters, J. V. Busik, L. K. Olson, et al. 2006. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 47: 2028-2041. (Pubitemid 44401991)